These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35907101)

  • 61. Persistent Bacillus Calmette-Guerin Reaction: A Potential Clue to Underlying Immune Deficiency.
    Khalsa A; Rubin AI; Jen M
    Pediatr Dermatol; 2015; 32(5):e215-6. PubMed ID: 26059661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
    Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
    Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes.
    Gonzalez B; Moreno S; Burdach R; Valenzuela MT; Henriquez A; Ramos MI; Sorensen RU
    Pediatr Infect Dis J; 1989 Apr; 8(4):201-6. PubMed ID: 2654859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.
    Marciano BE; Huang CY; Joshi G; Rezaei N; Carvalho BC; Allwood Z; Ikinciogullari A; Reda SM; Gennery A; Thon V; Espinosa-Rosales F; Al-Herz W; Porras O; Shcherbina A; Szaflarska A; Kiliç Ş; Franco JL; Gómez Raccio AC; Roxo P; Esteves I; Galal N; Grumach AS; Al-Tamemi S; Yildiran A; Orellana JC; Yamada M; Morio T; Liberatore D; Ohtsuka Y; Lau YL; Nishikomori R; Torres-Lozano C; Mazzucchelli JT; Vilela MM; Tavares FS; Cunha L; Pinto JA; Espinosa-Padilla SE; Hernandez-Nieto L; Elfeky RA; Ariga T; Toshio H; Dogu F; Cipe F; Formankova R; Nuñez-Nuñez ME; Bezrodnik L; Marques JG; Pereira MI; Listello V; Slatter MA; Nademi Z; Kowalczyk D; Fleisher TA; Davies G; Neven B; Rosenzweig SD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1134-41. PubMed ID: 24679470
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.
    Norouzi S; Aghamohammadi A; Mamishi S; Rosenzweig SD; Rezaei N
    J Infect; 2012 Jun; 64(6):543-54. PubMed ID: 22430715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
    Rermruay R; Rungmaitree S; Chatpornvorarux S; Brukesawan C; Wittawatmongkol O; Lapphra K; Phongsamart W; Kongstan N; Khumcha B; Chokephaibulkit K
    Vaccine; 2018 Jun; 36(28):4046-4053. PubMed ID: 29859799
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study.
    Ying W; Sun J; Liu D; Hui X; Yu Y; Wang J; Wang X
    PLoS One; 2014; 9(4):e94485. PubMed ID: 24722620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bacillus Calmette-Guérin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Ishikawa T; Okai M; Mochizuki E; Uchiyama T; Onodera M; Kawai T
    Clin Infect Dis; 2021 Nov; 73(9):e2538-e2544. PubMed ID: 32712647
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disseminated Bacille Calmette-Guérin disease as the initial presentation of X-linked severe combined immunodeficiency--a case report.
    Huang LH; Shyur SD; Weng JD; Shin-Chi ; Tzen CY; Huang FY
    Asian Pac J Allergy Immunol; 2005 Dec; 23(4):221-6. PubMed ID: 16572742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guérin vaccination: A national surveillance study in Japan from 2013 to 2017.
    Okuno H; Satoh H; Morino S; Arai S; Ochiai M; Fujita K; Naito S; Kato A; Ishii K; Oishi K; Suzuki M; Tanaka-Taya K
    Vaccine; 2022 Aug; 40(33):4922-4928. PubMed ID: 35690499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A case diagnosed with chronic granulomatous disease after disseminated infection following BCG vaccination].
    Delibalta G; Seringeç M; Öncül O
    Mikrobiyol Bul; 2015 Jul; 49(3):461-6. PubMed ID: 26313288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants.
    Zufferey C; Germano S; Dutta B; Ritz N; Curtis N
    PLoS One; 2013; 8(10):e77334. PubMed ID: 24098583
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Successful treatment of disseminated BCG infection in a SCID patient with granulocyte colony stimulating factor.
    Pariyaprasert W; Pacharn P; Visitsunthorn N; Chokephaibulkit K; Sanpakit K; Viprakasit V; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008 Mar; 26(1):71-5. PubMed ID: 18595532
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A rare mutation causing autosomal dominant STAT1 deficiency in a South African multiplex kindred with disseminated BCG infection.
    Greybe L; Leung D; Wieselthaler N; le Roux DM; Chan KW; Lau YL; Eley B
    BMC Pediatr; 2023 Jul; 23(1):378. PubMed ID: 37516851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
    Errami A; Baghdadi JE; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Rada N; Benajiba N; Mokhantar K; Ouazahrou K; Zaidi S; Abel L; Casanova JL; Boisson-Dupuis S; Bustamante J; Bousfiha AA
    J Clin Immunol; 2023 May; 43(4):728-740. PubMed ID: 36630059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
    Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
    Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
    [TBL] [Abstract][Full Text] [Related]  

  • 79. BCG Vaccine-associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity.
    Al-Herz W; Husain EH; Adeli M; Al Farsi T; Al-Hammadi S; Al Kuwaiti AA; Al-Nesf M; Al Sukaiti N; Al-Tamemi S; Shendi H
    Pediatr Infect Dis J; 2022 Nov; 41(11):933-937. PubMed ID: 36102730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.
    Mahmoudi S; Khaheshi S; Pourakbari B; Aghamohammadi A; Keshavarz Valian S; Bahador A; Sabouni F; Ramezani A; Mamishi S
    Clin Exp Vaccine Res; 2015 Jul; 4(2):195-9. PubMed ID: 26273579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.